A patient with a usual bedtime blood glucose of about 170 mg/dL on 12–15 units of insulin glargine (Lantus) asks whether the basal insulin dose should be changed when the current bedtime glucose is 132 mg/dL; should the dose remain the same or be adjusted?

Basal Insulin Dosing with Lower Bedtime Glucose

The patient should administer the same dose of 12-15 units of glargine/Lantus despite the lower bedtime glucose of 132 mg/dL, as basal insulin is dosed based on fasting plasma glucose (FPG) targets—not bedtime values—and should not be adjusted for day-to-day fluctuations. 1

Understanding Basal Insulin Pharmacology

Glargine (Lantus) is a long-acting basal insulin designed to provide relatively constant glucose-lowering activity over 24 hours 1. Its primary function is to restrain hepatic glucose production overnight and between meals, with dosing adjustments based on fasting glucose patterns, not individual bedtime readings 2.

Key Dosing Principles

Basal Insulin is NOT Adjusted for Bedtime Glucose

• Basal insulin dose remains constant regardless of bedtime blood sugar because it works throughout the entire 24-hour period to control fasting glucose 1
• The FDA label explicitly states that Lantus "should be administered subcutaneously once a day at the same time every day" with dose adjustments made based on clinical response over time, not single measurements 1
• According to the 2025 ADA Standards, basal insulin titration should follow evidence-based algorithms that increase doses by 2 units every 3 days to reach fasting plasma glucose (FPG) goals without hypoglycemia 2

When to Actually Adjust Basal Insulin

The patient's basal insulin dose should be evaluated and potentially adjusted based on:

• Fasting morning glucose patterns over several days (not bedtime values) 2, 3
• Target FPG is typically 80-130 mg/dL (4.4-7.2 mmol/L) 3
• If fasting glucose consistently runs high, increase the basal dose by 2 units every 3 days 2
• If experiencing hypoglycemia without clear cause, reduce dose by 10-20% 2

Common Pitfall to Avoid

Do not "correct" basal insulin doses based on single bedtime glucose readings. This is a fundamental error in insulin management. Bedtime glucose of 132 mg/dL is actually reasonable (target range is typically 80-180 mg/dL before bed), and adjusting basal insulin for this reading would lead to:

• Erratic dosing patterns that prevent stable glycemic control 1
• Potential morning hypoglycemia if the dose is inappropriately reduced 2
• Confusion between basal insulin (which controls background glucose) and correction/prandial insulin (which addresses acute elevations) 2

Clinical Algorithm for This Patient

1. Tonight: Give the usual 12-15 units of glargine at the regular time 1
2. Monitor fasting glucose (before breakfast) for the next 3-7 days 2, 3
3. If fasting glucose averages >130 mg/dL: Increase basal dose by 2 units 2
4. If fasting glucose averages 80-130 mg/dL: Continue current dose 2, 3
5. If experiencing morning hypoglycemia (<70 mg/dL): Reduce dose by 10-20% 2

The bedtime value of 132 mg/dL is simply a data point showing reasonable pre-sleep glucose control and requires no immediate action regarding basal insulin dosing 1.